HCA Healthcare (HCA)
point-in-time fundamentals
The latest fundamentals for HCA Healthcare that were publicly knowable as of 2026-02-10, straight from its SEC filings. Every value is stamped with the date it first became public — so a backtest of HCA can only see what was real at the time. No lookahead bias.
Latest knowable fundamentals
| Concept | FY | First-reported value | Became public |
|---|---|---|---|
| Revenue | FY2025 | $75.6B | 2026-02-10 |
| Net income | FY2025 | $6.8B | 2026-02-10 |
| Total assets | FY2025 | $60.7B | 2026-02-10 |
| Stockholders' equity | FY2025 | $-6.0B | 2026-02-10 |
| Operating cash flow | FY2025 | $12.6B | 2026-02-10 |
| Diluted EPS | FY2025 | $28.33 | 2026-02-10 |
| Diluted shares | FY2025 | 239M sh | 2026-02-10 |
| Pretax income | FY2025 | $9.8B | 2026-02-10 |
| Income tax expense | FY2025 | $2.0B | 2026-02-10 |
| Capital expenditures | FY2025 | $4.9B | 2026-02-10 |
| Cash and cash equivalents | FY2025 | $1.0B | 2026-02-10 |
| Current assets | FY2025 | $15.8B | 2026-02-10 |
| Current liabilities | FY2025 | $16.4B | 2026-02-10 |
| Net property, plant & equipment | FY2025 | $31.1B | 2026-02-10 |
Revenue, as first reported
What HCA's annual revenue was on the day each 10-K was filed — the honest number a backtest could have used.
| Fiscal year | Revenue (first reported) | Filed |
|---|---|---|
| FY2025 | $75.6B | 2026-02-10 |
| FY2024 | $70.6B | 2025-02-14 |
| FY2023 | $65.0B | 2024-02-16 |
| FY2022 | $60.2B | 2023-02-17 |
| FY2021 | $58.8B | 2022-02-18 |
| FY2020 | $51.5B | 2021-02-19 |
curl "https://tradevodata.com/v1/fundamentals?ticker=HCA&as_of=2023-06-30" \ -H "x-api-key: tvd_your_key"
For any as_of date, the API returns each concept's latest value that was already public then — a point-in-time snapshot, not a multi-year array. Walk history by repeating the request with earlier as_of dates. This page shows only the latest snapshot.
Backtest HCA — and 5,169 others — without lookahead bias.
This page shows the latest annual snapshot. Add period=quarterly to the API request for Q1–Q3 and supported Q4 history; derived rows identify their method.
Source: U.S. SEC EDGAR (public domain). Values are first-reported (point-in-time); not investment advice. Verify against primary filings before relying on them.